/ Print /

Health Management

Game-changing cholesterol-buster further reduces heart attack, strokeA new outcomes study shows that the PCSK9 inhibitor Repatha significantly reduced the risk of hard major adverse cardiovascular events in high-risk patients by 20%.
Partnership aims to make insulin more affordableCVS, Novo Nordisk launch a prescription savings program to help patients afford essential medications.
Regulatory changes for community oncology: What health execs should knowOne thing that is unlikely to change under the new Administration is the goal of reducing the cost of healthcare through various alternative payment initiatives. Here’s how that will affect oncology.
Four steps managed care can take to promote antimicrobial stewardshipThe call for antimicrobial stewardship is growing. Enact these steps to prevent a return to the pre-antibiotic era.
Game changing idea: Specialty intensive medical homeBlue Cross Blue Shield of Illinois partners with gastroenterology group to focus on Crohn’s disease patients.
Behavioral health top priority for employersWith a growing need for services, nearly nine in 10 employers cite behavioral health as an important priority in Willis Towers Watson survey.
Prescribing practices that increase risk of opioid overdoseTwo studies, one from Prime Therapeutics and Stanford, reveal an alarming increase in overdose with concurrent use of opioids and benzodiazepines. Here’s how managed care can help.
Five advancements in diabetes treatment to watch
Five advancements in diabetes treatment to watchThe healthcare industry continues to focus efforts on treatments that work better, and ideally are less expensive and less invasive for patients.
New C-suite position to watch: Chief experience officers
New C-suite position to watch: Chief experience officersChief experience officers improve the patient experience—and the experience of caregivers.
Incremental clinical advances for Duchenne Muscular DystrophyJust last year, the FDA approved Exondys 51 (eteplirsen) for DMD, over the recommendations of FDA scientists and an external scientific advisory committee. Read more.